Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAA50 | Q9GZZ1 | 2/20 | 0.86 |
| ▸ | CHAT | P28329 | 2/20 | 0.82 |
| ▸ | EP300 | Q09472 | 3/20 | 0.81 |
| ▸ | KAT5 | Q92993 | 2/20 | 0.81 |
| ▸ | AURKA | O14965 | 2/20 | 0.81 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.81 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.72 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hexanoyl-Coa SCHEMBL11940278 | 1.00 | NAA50 (0.86) | NAA50CHATEP300KAT5AURKA | |
| Hexanoyl-Coa SCHEMBL60392 | 1.00 | NAA50 (0.86) | NAA50CHATEP300KAT5AURKA | |
| Octanoyl-Coa SCHEMBL2370508 | 0.99 | NAA50 (0.85) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL11027446 | 0.99 | NAA50 (0.85) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL2934083 | 0.99 | NAA50 (0.85) | NAA50CHATEP300KAT5AURKA | |
| Decanoyl-Coa SCHEMBL24667667 | 0.99 | NAA50 (0.85) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL1756475 | 0.99 | NAA50 (0.85) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL20970006 | 0.99 | NAA50 (0.85) | NAA50CHATEP300KAT5AURKA | |
| Octanoyl-Coa SCHEMBL24667663 | 0.99 | NAA50 (0.85) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL1129961 | 0.99 | NAA50 (0.85) | NAA50CHATEP300KAT5AURKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 171 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3998336-B1 | MICROORGANISMS AND METHODS FOR PRODUCING CANNABINOIDS AND CANNABINOID DERIVATIVES | UNIV CALIFORNIA (US) | 2026-01-07 | — | — | EP | claimed |
| US-20240368613-A1 | NON-ENDOGENOUS PRODUCTION OF CANNABINOIDS AND CANNABINOID PRECURSOR COMPOUNDS IN PLANT SYSTEMS | UNIV COLORADO REGENTS (US) | 2024-11-07 | — | — | US | claimed |
| US-20240360425-A1 | ENGINEERED ENZYMES, CELLS, AND METHODS FOR PRODUCING CANNABINOID PRECURSORS AND CANNABINOIDS | CELLIBRE, INC. | 2024-10-31 | — | — | US | claimed |
| US-20240279694-A1 | PRODUCTION OF CANNABINOIDS IN YEAST | BIOMEDICAN INC (US) | 2024-08-22 | — | — | US | claimed |
| US-20230279452-A1 | PREPARING AND MODIFYING MEROTERPENE POLYKETIDES, KETONES, AND LACTONES FOR CANNABINOID SEMISYNTHESIS | LYGOS, INC. | 2023-09-07 | — | — | US | claimed |
| CN-110914416-B | Microorganism and method for producing cannabinoids and cannabinoid derivatives | 加州大学董事会 | 2023-07-21 | — | — | CN | claimed |
| WO-2023069921-A1 | RECOMBINANT THCA SYNTHASE POLYPEPTIDES ENGINEERED FOR ENHANCED BIOSYNTHESIS OF CANNABINOIDS | EPIMERON USA, INC. (US) | 2023-04-27 | — | — | WO | claimed |
| CN-115725665-A | Hyperforin biosynthesis gene cluster and application thereof | 中国科学院分子植物科学卓越创新中心 | 2023-03-03 | — | — | CN | claimed |
| US-20220403346-A1 | PRODUCTION OF CANNABINOIDS | BIOMEDICAN, INC. | 2022-12-22 | — | — | US | claimed |
| EP-4103679-A1 | PREPARING AND MODIFYING MEROTERPENE POLYKETIDES, KETONES, AND LACTONES FOR CANNABINOID SEMISYNTHESIS | Lygos, Inc. (US) | 2022-12-21 | — | — | EP | claimed |
| WO-2022241299-A2 | ENGINEERED ENZYMES, CELLS, AND METHODS FOR PRODUCING CANNABINOID PRECURSORS AND CANNABINOIDS | CELLIBRE, INC. (US) | 2022-11-17 | — | — | WO | claimed |
| WO-2022221367-A1 | NON-ENDOGENOUS PRODUCTION OF CANNABINOIDS AND CANNABINOID PRECURSOR COMPOUNDS IN PLANT SYSTEMS | THE REGENTS OF THE UNIVERSITY OF COLORADO A BODY CORPORATE (US) | 2022-10-20 | — | — | WO | claimed |
| CN-115151643-A | Biosynthetic platform for the production of olivinic acid and olivinic acid analogs | 加利福尼亚大学董事会 | 2022-10-04 | — | — | CN | claimed |
| US-20220213513-A1 | PRODUCTION OF CANNABINOIDS | BIOMEDICAN, INC. | 2022-07-07 | — | — | US | claimed |
| EP-4017972-A1 | PRODUCTION OF CANNABINOIDS | Biomedican, Inc. (US) | 2022-06-29 | — | — | EP | claimed |
| CN-107075523-B | Cannabichromenic acid synthase from cannabis | 加拿大国家研究委员会 | 2022-04-19 | — | — | CN | claimed |
| CN-114262695-A | Saccharomyces cerevisiae engineering bacterium for producing CBGA precursor and construction method and application thereof | 杭州恩和生物科技有限公司 | 2022-04-01 | — | — | CN | claimed |
| CN-110892075-A | Production of cannabinoids in yeast | 生物医学股份有限公司 | 2020-03-17 | — | — | CN | claimed |
| EP-3998336-B1 | MICROORGANISMS AND METHODS FOR PRODUCING CANNABINOIDS AND CANNABINOID DERIVATIVES | UNIV CALIFORNIA (US) | 2026-01-07 | — | — | EP | disclosed |
| CN-1298006-A | Eucaryon transacetylase 11 as one new kind of polypeptide and polynucleotides encoding this polypeptide | SHANGHAI BORONG GENE DEV CO (CN) | 2001-06-06 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220213513-A1 | PRODUCTION OF CANNABINOIDS | DGAT2, GGPS1, UGCG | NAA50 287/4885CHAT 2061/4885EP300 1875/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.